BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang F, Li X, Jia X, Geng L. CircRNA ZNF609 Knockdown Represses the Development of Non-Small Cell Lung Cancer via miR-623/FOXM1 Axis. Cancer Manag Res 2021;13:1029-39. [PMID: 33574702 DOI: 10.2147/CMAR.S282162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Luo J, Wang S, Zhang L, Zhang L, Wu S, Zheng W, Huang X, Ye X, Wu M. Research advance and clinical implication of circZNF609 in human diseases. Biotechnology & Biotechnological Equipment 2022;36:668-683. [DOI: 10.1080/13102818.2022.2118076] [Reference Citation Analysis]
2 Wang S, Wu J, Wang Z, Gong Z, Liu Y, Wang Z. Emerging Roles of Circ-ZNF609 in Multiple Human Diseases. Front Genet 2022;13:837343. [DOI: 10.3389/fgene.2022.837343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol 2022;19:188-206. [PMID: 34912049 DOI: 10.1038/s41571-021-00585-y] [Cited by in Crossref: 104] [Cited by in F6Publishing: 99] [Article Influence: 104.0] [Reference Citation Analysis]
4 Shi P, Liu Y, Yang D, Wu Y, Zhang L, Jing S, Shi H, Geng C. CircRNA ZNF609 promotes the growth and metastasis of thyroid cancer in vivo and in vitro by downregulating miR-514a-5p. Bioengineered 2022;13:4372-84. [PMID: 35135416 DOI: 10.1080/21655979.2022.2033015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
5 Qian Y, Li Y, Li R, Yang T, Jia R, Ge YZ. circ-ZNF609: A potent circRNA in human cancers. J Cell Mol Med 2021;25:10349-61. [PMID: 34697887 DOI: 10.1111/jcmm.16996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Dong H, Zhou J, Cheng Y, Wang M, Wang S, Xu H. Biogenesis, Functions, and Role of CircRNAs in Lung Cancer. Cancer Manag Res 2021;13:6651-71. [PMID: 34466035 DOI: 10.2147/CMAR.S324812] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]